The role of orexin in Parkinson's disease
Authors:
Open Access
- 23 March 2024
- journal article
- review article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 102 (3) , e25322
Abstract
Emerging evidence has implicated the orexin system in non‐motor pathogenesis of Parkinson's disease. It has also been suggested the orexin system is involved in the modulation of motor control, further implicating the orexin system in Parkinson's disease. Parkinson's disease is the second most common neurodegenerative disease with millions of people suffering worldwide with motor and non‐motor symptoms, significantly affecting their quality of life. Treatments are based solely on symptomatic management and no cure currently exists. The orexin system has the potential to be a treatment target in Parkinson's disease, particularly in the non‐motor stage. In this review, the most current evidence on the orexin system in Parkinson's disease and its potential role in motor and non‐motor symptoms of the disease is summarized. This review begins with a brief overview of Parkinson's disease, animal models of the disease, and the orexin system. This leads into discussion of the possible roles of orexin neurons in Parkinson's disease and levels of orexin in the cerebral spinal fluid and plasma in Parkinson's disease and animal models of the disease. The role of orexin is then discussed in relation to symptoms of the disease including motor control, sleep, cognitive impairment, psychological behaviors, and the gastrointestinal system. The neuroprotective effects of orexin are also summarized in preclinical models of the disease.Keywords
Funding Information
- Neurosurgical Research Foundation
This publication has 142 references indexed in Scilit:
- MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCIMovement Disorders, 2011
- The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?Movement Disorders, 2008
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 yearsMovement Disorders, 2008
- Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological studyMovement Disorders, 2008
- Orexins and Orexin Receptors: From Molecules to Integrative Physiology2008
- Prevalence and Characteristics of Dementia in Parkinson DiseaseArchives of Neurology, 2003
- The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other HypersomniasArchives of Neurology, 2002
- Differential expression of orexin receptors 1 and 2 in the rat brainJournal of Comparative Neurology, 2001
- Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia NigraExperimental Neurology, 2000
- Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic systemJournal of Comparative Neurology, 1999